Patrick Rousseau

Patrick Rousseau is currently a Business Process Owner for Deviation & Investigation at Sanofi and has previously served as the Global Process Owner for Complaints Management at the same company. With a robust background in quality and regulatory affairs, Patrick held various pivotal roles at esteemed organizations including Aspen Pharma, Pfizer, GSK, and UCB. Notably, Patrick was the Quality Director and Chief Pharmaceutical Officer at Aspen Pharma from 2016 to 2019, where they oversaw critical quality management processes. Patrick earned a degree from Université Paris Sud (Paris XI) between 1985 and 1992.